The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Metastatic Melanoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Metastatic Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Metastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape. The...
April 2021
425 pages
microRNA 21 (MIR21) - Drugs in Development, 2021
US$ 3,000.00
microRNA 21 (MIR21) - Drugs in Development, 2021 SUMMARY microRNA 21 (MIR21) - Drugs in Development, 2021 provides in depth analysis on microRNA 21 (MIR21) targeted pipeline therapeutics. The report p...
April 2021
30 pages
Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Muscle Spasm pipeline landscape. The report...
April 2021
30 pages
